10-Q: Waystar Reports Strong Q2 Growth, Swings to Profit, and Announces Major AI Acquisition

Waystar Holding Corp. announced robust financial results for the second quarter and first half of 2025, marked by significant revenue growth, a return to net profitability, and a strategic $1.25 billion acquisition of AI-powered clinical intelligence leader Iodine Software Holdings, Inc.

Summary

• Revenue for the three months ended June 30, 2025, increased by 15.4% to $270.7 million, up from $234.5 million in the prior year period.
• Net income for the second quarter of 2025 was $32.2 million, a significant improvement from a net loss of $27.7 million in the same period last year.
• For the six months ended June 30, 2025, revenue grew 14.8% to $527.1 million, compared to $459.3 million in the first half of 2024.
• Net income for the first half of 2025 reached $61.5 million, a substantial turnaround from a net loss of $43.6 million in the first half of 2024.
• Adjusted EBITDA for the six months ended June 30, 2025, increased by 18.0% to $220.3 million, with an Adjusted EBITDA margin of 41.8%.
• The Net Revenue Retention Rate for the twelve months ended June 30, 2025, was 114.6%, up from 107.5% in the prior year.
• The company's client base generating over $100,000 in revenue increased to 1,268 as of June 30, 2025, from 1,117 in the prior year.
• Interest expense significantly decreased by $32.3 million for the three months and $70.6 million for the six months ended June 30, 2025, primarily due to $1.0 billion in First Lien Credit Facility paydowns in 2024.
• The company entered into an agreement to acquire Iodine Software Holdings, Inc. for $1.25 billion, comprising $625.0 million in cash and 16,751,541 shares of common stock, expected to close by year-end 2025.

Sentiment

Score: 8

Explanation: The company demonstrates strong financial performance with significant revenue growth, a positive swing to net income, and improved margins. The strategic acquisition of Iodine Software Holdings, Inc. is a key positive, bolstering AI capabilities and market position. The high Net Revenue Retention Rate and expanding client base are also very favorable. While the healthcare industry is highly regulated and competitive, and integration risks exist with the acquisition, the overall trajectory and strategic initiatives are highly positive.

Positives

• Achieved significant revenue growth of 15.4% for Q2 2025 and 14.8% for H1 2025, driven by both subscription and volume-based revenue expansion.
• Successfully transitioned from a net loss to a net income of $32.2 million in Q2 2025 and $61.5 million in H1 2025, demonstrating improved profitability.
• Reported a strong Net Revenue Retention Rate of 114.6%, indicating effective client retention and expansion of services to existing clients.
• Increased the number of clients generating over $100,000 in revenue to 1,268, reflecting growth in high-value customer relationships.
• Realized substantial reductions in interest expense due to strategic debt paydowns, positively impacting the bottom line.
• Announced the strategic acquisition of Iodine Software Holdings, Inc., expected to bolster AI capabilities and enhance clinical intelligence offerings.
• Maintained a strong Adjusted EBITDA margin of 41.8% for the first half of 2025, indicating efficient operations and cost management.

Negatives

• Increased costs of revenue by 8.2% for Q2 2025 and 9.5% for H1 2025, primarily due to higher transaction volumes and associated third-party costs.
• Incurred incremental public company expenses following the IPO, affecting general and administrative costs.
• The Iodine acquisition, while strategic, involves a significant cash component of $625.0 million and issuance of 16,751,541 shares, which could lead to dilution for existing shareholders.

Risks

• Operating in a highly competitive industry.
• Ability to retain existing clients and attract new clients.
• Ability to successfully execute business strategies and integrate acquired businesses, including Iodine Software Holdings, Inc.
• Dependence on the senior management team and key employees, and the ability to attract and retain highly skilled employees.
• Accuracy of estimates and assumptions used to determine the size of the total addressable market.
• Ability to develop and market new solutions, or enhance existing solutions, to respond to technological changes or evolving industry standards.
• Interoperability, connectivity, and integration of solutions with clients' and their vendors' networks and infrastructures.
• Performance and reliability of internet, mobile, and other infrastructure.
• Consequences if the company cannot obtain, process, use, disclose, or distribute the highly regulated data required to provide solutions.
• Reliance on certain third-party vendors and providers.
• Potential for errors or malfunctions in products and solutions.
• Failure by clients to obtain proper permissions or provide accurate and appropriate information.
• Potential for embezzlement, identity theft, or other similar illegal behavior by employees or vendors.
• Compliance with applicable rules of the National Automated Clearing House Association and card network requirements.
• Increases in card network fees and other changes to fee arrangements.
• Effect of payer and provider conduct which the company cannot control.
• Privacy concerns and security breaches or incidents relating to the platform.
• Complex and evolving laws and regulations regarding privacy, data protection, and cybersecurity.
• Ability to adequately protect and enforce intellectual property rights.
• Legal proceedings initiated by third parties alleging intellectual property infringement.
• Claims that employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties.
• The heavily regulated healthcare industry in which the company conducts business.
• The uncertain and evolving healthcare regulatory and political framework.
• Reduced revenues in response to changes to the healthcare regulatory landscape.
• Legal, regulatory, and other proceedings that could result in adverse outcomes.
• Consumer protection laws and regulations.
• Contractual obligations requiring compliance with certain provisions of Bank Secrecy Act/anti-money laundering laws and regulations.
• Existing laws that regulate the ability to engage in certain marketing activities.
• Full compliance with website accessibility standards.
• Any changes in tax rates, the adoption of new tax legislation, or exposure to additional tax liabilities.
• Limitations on the ability to use net operating losses to offset future taxable income.
• Losses due to asset impairment charges.
• Restrictive covenants in the agreements governing Credit Facilities.
• Interest rate fluctuations.
• Unavailability of additional capital on acceptable terms or at all.
• The impact of general macroeconomic conditions.
• History of net losses and ability to achieve or maintain profitability.
• The interests of the Institutional Investors may be different than the interests of other holders of the company's securities.
• Status as an emerging growth company and whether reduced disclosure requirements will make common stock less attractive to investors.

Future Outlook

The company anticipates continued growth, with provider solutions expected to remain the primary revenue driver, while patient payment solutions are projected to increase slightly over time. Future growth and profitability are dependent on expanding relationships with existing clients through cross-selling and up-selling, as well as growing the overall client base by maintaining product leadership, investing in research and development, and strengthening brand reputation. The acquisition of Iodine Software Holdings, Inc. is expected to further bolster AI leadership, automate manual work, and improve financial performance for providers. The company is currently evaluating the impact of the recently signed H.R.1, the 'One Big Beautiful Bill Act,' on its financial statements.

Management Comments

• Our business model is designed such that as our clients grow to serve more patients, their claims and transactional volumes increase, resulting in corresponding growth in our business.
• Our clients frequently adopt a greater number of our solutions over time and introduce our solutions across new sites of care.
• Our platform benefits from powerful network effects. Our cloud-based software is driven by a sophisticated, automated, and curated rules engine, employing AI to generate and incorporate real-time feedback from millions of network transactions processed through our platform each day.
• Every transaction we process provides additional data insights across providers, patients, and payers, which are embedded in updates that are deployed efficiently across our client base.
• This results in cumulative benefits to us over time as we capture more data from each transaction we process, we leverage that data to continue to improve the Waystar platform through embedded machine learning, advanced algorithms, and other in-house AI technologies to deliver added value to our clients.
• In turn, the more value we create for our clients, the more likely it is that they will continue to use our products, allowing us to continue to capture more data that results in tangible improvements to our platform.
• As a result, our clients benefit from faster and more efficient performance from software that is evolving to meet ever-changing regulatory and payer requirements, enabling accurate and timely reimbursement.
• We have demonstrated an ability to drive recurring, predictable, and profitable growth.
• Over 99% of our revenue is either recurring subscription or based on highly predictable volumes.

Industry Context

Waystar operates in the highly complex and evolving U.S. healthcare payments industry, providing mission-critical cloud technology. The company leverages AI and proprietary algorithms to automate and streamline healthcare payment processes, from pre-service engagement to post-service remittance. This focus on efficiency, data integrity, and cost reduction aligns with broader industry trends towards digital transformation and AI adoption in healthcare to address administrative burdens and improve financial outcomes for providers. The acquisition of Iodine Software Holdings, Inc., a leader in AI-powered clinical intelligence, further solidifies Waystar's position at the forefront of integrating advanced technology to enhance clinical documentation, utilization management, and revenue cycle integrity within the healthcare ecosystem.

Comparison to Industry Standards

• The Net Revenue Retention Rate of 114.6% for the twelve months ended June 30, 2025, is a strong indicator of customer satisfaction and successful upsell/cross-sell strategies, significantly outperforming the typical SaaS industry benchmark of 100% and approaching the excellent range of 120% or higher.
• Serving over 30,000 clients, including 16 of the top 20 U.S. News Best Hospitals, demonstrates a robust market presence and strong adoption among leading healthcare institutions, indicating competitive strength against peers in the healthcare technology sector.
• Facilitating over six billion healthcare payment transactions and approximately 50% of patients in the United States in 2024 highlights a dominant market share and extensive network effects, positioning the company as a critical infrastructure provider in the U.S. healthcare system, a scale few competitors can match.

Management Changes

Corporate Governance

Legal Proceedings

• The company may be subject to legal proceedings, claims, asserted or unasserted, and litigation arising in the ordinary course of business.
• The ultimate costs to resolve any pending matters are not currently expected to have a material effect on the consolidated financial position, results of operations, or cash flows.

Related Party Transactions

• Outstanding debt of $56.2 million as of June 30, 2025, from Bain Affiliated Funds and CPPIB Credit Investments III Inc. (Affiliated Debtholders) as part of the First Lien Credit Facility.
• Interest expense paid to Affiliated Debtholders was $0.9 million for Q2 2025 and $1.6 million for H1 2025.
• CPPIB, an owner, has a significant interest in a landlord from whom the company leases office space in Houston, Texas; no expense was recorded for this lease in Q2 2025 or H1 2025.
• Bain Capital LP, an owner, has a significant interest in five clients from whom the company earned $0.6 million in revenue in Q2 2025 and $1.2 million in H1 2025.
• Bain Capital LP also has a significant interest in two vendors providing software solutions, from whom the company expensed $0.6 million in Q2 2025 and $1.2 million in H1 2025 for software services.

Stakeholder Impact

• Shareholders: Positive impact from strong financial performance, increased profitability, and strategic acquisition, potentially leading to increased share value. Dilution from shares issued for the Iodine acquisition is a consideration.
• Employees: Benefit from stock-based compensation plans (2019 Stock Incentive Plan, 2024 Equity Incentive Plan, 2024 Employee Stock Purchase Plan) and potential growth opportunities from the Iodine acquisition.
• Customers (Healthcare Providers): Expected to benefit from enhanced AI-powered solutions, improved data integrity, reduced labor costs, faster and more accurate reimbursement, and expanded offerings through the Iodine acquisition.
• Creditors: Reduced interest expense due to prior debt paydowns improves the company's financial health, while compliance with debt covenants is maintained.
• Suppliers/Vendors: Continued business relationships, including with related-party vendors, as the company expands operations and integrates new technologies.

Next Steps

• Closing of the acquisition of Iodine Software Holdings, Inc. is expected by year-end 2025, subject to customary closing conditions and regulatory approvals.
• Evaluation of the effect of H.R.1, the 'One Big Beautiful Bill Act,' on the consolidated and condensed consolidated financial statements.
• Continued focus on expanding relationships with existing clients through cross-selling and up-selling additional solutions.
• Ongoing efforts to grow the client base by maintaining product leadership, investing in research and development, and strengthening brand and reputation.

Key Dates

Recommendation

The company's Q2 and H1 2025 results demonstrate exceptional financial health, marked by a significant swing from net losses to substantial net income, robust revenue growth, and improved Adjusted EBITDA margins. The Net Revenue Retention Rate of 114.6% signals strong customer loyalty and expansion, a key indicator of sustainable SaaS business growth. The strategic acquisition of Iodine Software Holdings, Inc. is a transformative move, bolstering the company's AI capabilities and market leadership in clinical intelligence, which is critical for future growth in the healthcare technology sector. Furthermore, effective debt management has significantly reduced interest expenses, enhancing profitability. While the acquisition introduces integration risks and potential dilution, the overall positive financial trajectory, strategic positioning, and strong operational metrics make Waystar a compelling 'strong buy' for seasoned investors seeking exposure to the high-growth healthcare technology market.

Keywords

Healthcare Technology, Healthcare Payments, Cloud Software, AI, Artificial Intelligence, Revenue Cycle Management, Medical Billing, Patient Payments, Provider Solutions, SaaS, Software as a Service, SEC Filing, 10-Q, Financial Results, Acquisition, Iodine Software, Net Revenue Retention Rate